Predictive value of neutrophil-to-lymphocyte ratio on drug eluting stent restenosis in patients with type 2 diabetes mellitus

Predictive value of neutrophil-to-lymphocyte ratio on drug eluting stent restenosis in patients with type 2 diabetes mellitus

Bibliographic Details
Main Authors:	Zhi-Chao Wang, Jian-Ning Zhang, Zhe Zhou, Jun Tao, Ning-Ning Wang
Format:	Article
Language:	English
Published:	Wolters Kluwer 2020-10-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000001045

Similar Items

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
by: Nisha Ohri, MD, et al.
Published: (2016-01-01)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
by: Violeta Dinesch, et al.
Published: (2017-04-01)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Published: (2017-04-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
by: Sohila Refahi, et al.
Published: (2019-03-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
by: Mohamed Aboel-Kassem F. Abdelmegid, et al.
Published: (2017-04-01)

Platelet-to-lymphocyte and Neutrophil-to-lymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent Implantation
by: Silvia Lee, et al.
Published: (2020-06-01)

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence
by: Francesco Condello, et al.
Published: (2023-02-01)

The Predictive Value of Monocyte Count to High-Density Lipoprotein Cholesterol Ratio in Restenosis After Drug-Eluting Stent Implantation
by: Nan J, et al.
Published: (2020-11-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
by: Yen-Wen Liu, et al.
Published: (2021-09-01)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
by: Kakhaber Etsadashvili, et al.
Published: (2011-06-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
by: Hongfei Xi, et al.
Published: (2023-03-01)

Comparison of Neoatherosclerosis and Neovascularization of Restenosis after Drug-Eluting Stent Implantation: An Optical Coherence Tomography Study
by: Chancui Deng, et al.
Published: (2023-11-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
by: Omar A. Meelu, MS, et al.
Published: (2017-03-01)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
by: Porto, I, et al.
Published: (2005)

Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty
by: Mohd Shah, Azarisman Shah, et al.
Published: (2011)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Aslı Tanındı, et al.
Published: (2015-07-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Murat Gençbay
Published: (2015-07-01)

Random forest vs. logistic regression: Predicting angiographic in-stent restenosis after second-generation drug-eluting stent implantation
by: Zhi Jiang, et al.
Published: (2022-01-01)

Random forest vs. logistic regression: Predicting angiographic in-stent restenosis after second-generation drug-eluting stent implantation.
by: Zhi Jiang, et al.
Published: (2022-01-01)

The Predictive Value of the CHA2DS2-VASc Score for In-Stent Restenosis Among Patients with Drug-Eluting Stents Implantation
by: Zhao J, et al.
Published: (2023-01-01)

The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting
by: Hajizadeh Reza, et al.
Published: (2017-12-01)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
by: Jorge A Arroyave C, et al.
Published: (2012-06-01)

Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
by: Yu-Ling Hsu, et al.
Published: (2023-07-01)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
by: Huan Wang, et al.
Published: (2020-06-01)

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
by: Blackman, D, et al.
Published: (2003)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
by: Mohammad Saifur Rohman, et al.
Published: (2023-07-01)

The Role Of Inflammation In Stent Restenosis More Than 1 Year Afetr Drug Eluting Stent Implantation
by: Hasan Shemirani, et al.
Published: (2011-09-01)

The association between epicardial fat thickness in echocardiography and coronary restenosis in drug eluting stents
by: Fariborz Nikaeen, et al.
Published: (2011-04-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
by: Alain Guidon, et al.
Published: (2008-01-01)

In Stent Restenosis After Drug-Eluting Stent Implantation in a Patient with Polycythemia Vera: A Case Report
by: I Gusti Ayu Ratna Dewi, et al.
Published: (2023-06-01)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
by: Xiaohang Yuan, et al.
Published: (2023-08-01)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
by: Minsu Kim, et al.
Published: (2023-06-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
by: Jing Wang, et al.
Published: (2021-12-01)

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
by: Blackman, D, et al.
Published: (2004)

Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation
by: Zheng Qin, et al.
Published: (2017-01-01)

Comparison of the efficacy of drug-eluting balloon for de novo lesions and in-stent restenosis lesions of the femoropopliteal arteries
by: Yuefeng Zhu, et al.
Published: (2019-09-01)